<DOC>
	<DOC>NCT02545517</DOC>
	<brief_summary>The aim of this study is to evaluate the long-term (up to approx.10 years) persistence and to assess the boostability of immune responses in subjects who received a primary series of accelerated or conventional rabies PrEP IM regimen.</brief_summary>
	<brief_title>A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis.</brief_title>
	<detailed_description />
	<mesh_term>Rabies</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>All individuals who were randomized to a Rabies primary series vaccination for preexposure prophylaxis (PrEP), received the full PrEP regimen and completed the parent trial following study protocol. Completed the parent study without receiving the full 3 rabies vaccine doses following the assigned preexposure prophylaxis regimen. History of exposure to suspected or confirmed rabid animal. Receipt of rabies immunoglobulins, rabies post exposure prophylaxis following completion of the parent study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>